GPC3 and hepatocellular carcinoma: Thus, the immunomagnetic enrichment of GPC3+ CTCs and subsequent analysis by fluorescent activated cell sorter with anti-cytokeratin (CK, an epithelial marker) antibodies was postulated as a valid methodology to identify poor prognostic HCC patients.